Advances in developing novel therapeutic strategies for Alzheimer's disease.

Mol Neurodegener · 2018 · PMC6291983 · PMID 30541602

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

However, one trial that targeted delaying MCI conversion to AD, showed a trend towards benefits on selective cognitive tests and brain MRI measure ( NCT00000173 ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.